Sign In
Buy JAZZ
$252.86
-5.52 (-2.14%)
At Close: Jul 31, 2026
Top Insider Buys Highlight for the Week of May 29
10:01pm, Saturday, 30'th May 2020
Insiders loaded up on TJX Companies, Boston Properties, Royal Caribbean Cruises and Jazz Pharmaceuticals Continue reading...
Jazz Pharmaceuticals Announces Participation at Two Upcoming Virtual Investor Conferences
08:05pm, Wednesday, 27'th May 2020
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will webcast its corporate presentations at the following virtual investor conferences:
Jazz Pharmaceuticals to Showcase New Data From its Growing Oncology Portfolio at Virtual ASCO and EHA 2020 Meetings
01:55pm, Thursday, 14'th May 2020Jazz Pharmaceuticals to Showcase New Data From its Growing Oncology Portfolio at Virtual ASCO and EHA 2020 Meetings
01:53pm, Thursday, 14'th May 2020
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it and its partners will present seven new abstracts at the virtual American Society of Clinical Oncology (ASCO) Annual Meeting from May 29
Systematic Financial Management Lp Buys Onto Innovation Inc, Progress Software Corp, ...
12:00am, Tuesday, 12'th May 2020Jazz Pharmaceuticals Announces Appointment Of Kim Sablich As Executive Vice President, General Manager Of North America
12:30pm, Monday, 11'th May 2020
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the appointment of Kim Sablich as executive vice president, general manager of North America, effective June 1, 2020. In this role, Ms. Sablich
Why Jazz Pharmaceuticals' Symphony of Growth Is About to End
12:10pm, Saturday, 09'th May 2020
Competition is about to ramp up significantly in the $1.7 billion market for treating chronic sleep disorder.
Edited Transcript of JAZZ earnings conference call or presentation 5-May-20 8:30pm GMT
05:11am, Friday, 08'th May 2020
Q1 2020 Jazz Pharmaceuticals PLC Earnings Call
SunTrust Robinson Humphrey Maintains Buy on Jazz Pharmaceuticals, Lowers Price Target of $153
04:02pm, Wednesday, 06'th May 2020Jazz Pharma (JAZZ) Misses on Q1 Earnings & Sales, Cuts View
03:39pm, Wednesday, 06'th May 2020
Jazz Pharmaceuticals (JAZZ) reports lower-than-expected first-quarter 2020 earnings and revenues. It lowers its guidance for 2020. Shares drop.
